Atherosclerosis imaging with ¹⁸F-FDG PET is useful for detecting inflammation within plaque and monitoring the response to drug therapy. Here, PET and PET/CT images of femoral artery ¹⁸F-FDG uptake on days 1 and 14 demonstrate the strong temporal reproducibility of the technique. Measurement of target-to-background ratios may prove useful for assessing both systemic and plaque-focused therapies for atherosclerosis.
See page 871.